Team Careers Products Medical Affairs News Contact

Team Careers Products Medical Affairs News Contact

Back

Clinical Response to Third-Line Angiotensin-II vs Epinephrine in Septic Shock: A Propensity-Matched Cohort Study

April 11, 2024

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Careers Products Medical Affairs - Report Adverse Events - Report Product Complaints News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2024 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED